A new clinical trial at the University of Miami Miller School of Medicine will be the first in the U.S. to focus on using mesenchymal stem cells to treat Alzheimer’s Disease. “We believe infusions of stem cells have the potential to be beneficial to individuals with Alzheimer’s disease,” said Bernard S. Baumel, M.D., assistant professor of neurology, the principal investigator for the phase 1 clinical trial.
Miller School of Medicine researchers have found that the age of a donor mouse affects the ability of its mesenchymal stem cells (MSCs) to repair damage to the lungs caused by pulmonary fibrosis. Their laboratory study, published recently in Translational Research, has important implications for clinical stem cell treatments in older patients with damaged and scarred lung tissue caused by smoking or other conditions.
A new study from the University of Miami’s Interdisciplinary Stem Cell Institute has found that the sympathetic nervous system plays a vital role in heart regeneration. Prior to this study, scientists were aware of the potential for cardiac regeneration in the human neonatal period, but the factors involved in this process remained unknown.